Cerium Oxide Nanoparticles Inhibits Oxidative Stress and Nuclear Factor-κB Activation in H9c2 Cardiomyocytes Exposed to Cigarette Smoke Extract
- 4 April 2011
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 338 (1), 53-61
- https://doi.org/10.1124/jpet.111.179978
Abstract
Cigarette smoke contains and generates a large amount of reactive oxygen species (ROS) that affect normal cellular function and have pathogenic consequences in the cardiovascular system. Increased oxidative stress and inflammation are considered to be an important mechanism of cardiovascular injury induced by cigarette smoke. Antioxidants may serve as effective therapeutic agents against smoke-related cardiovascular disease. Because of the presence of oxygen vacancies on its surface and self-regenerative cycle of its dual oxidation states, Ce3+ and Ce4+, cerium oxide (CeO2) nanoparticles offer a potential to quench ROS in biological systems. In this study, we determined the ability of CeO2 nanoparticles to protect against cigarette smoke extract (CSE)-induced oxidative stress and inflammation in cultured rat H9c2 cardiomyocytes. CeO2 nanoparticles pretreatment of H9c2 cells resulted in significant inhibition of CSE-induced ROS production and cell death. Pretreatment of H9c2 cells with CeO2 nanoparticles suppressed CSE-induced phosphorylation of IκBα, nuclear translocation of p65 subunit of nuclear factor-κB (NF-κB), and NF-κB reporter activity in H9c2 cells. CeO2 nanoparticles pretreatment also resulted in a significant down-regulation of NF-κB-regulated inflammatory genes tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and inducible nitric-oxide synthase and further inhibited CSE-induced depletion of antioxidant enzymes, such as copper zinc superoxide dismutase, manganese superoxide dismutase, and intracellular glutathione content. These results indicate that CeO2 nanoparticles can inhibit CSE-induced cell damage via inhibition of ROS generation, NF-κB activation, inflammatory gene expression, and antioxidant depletion and may have a great potential for treatment of smoking-related diseases.This publication has 35 references indexed in Scilit:
- The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotalineInternational Journal of Nanomedicine, 2011
- Smoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A reviewAtherosclerosis, 2008
- Cardiac-Targeted Expression of Soluble Fas Attenuates Doxorubicin-Induced Cardiotoxicity in MiceThe Journal of pharmacology and experimental therapeutics, 2008
- The role of cerium redox state in the SOD mimetic activity of nanoceriaBiomaterials, 2008
- Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neuronsBiomaterials, 2007
- Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathyCardiovascular Research, 2007
- Vacancy Engineered Ceria Nanostructures for Protection from Radiation-Induced Cellular DamageNano Letters, 2005
- Transcription Factor NF‐κB: A Sensor for Smoke and Stress SignalsAnnals of the New York Academy of Sciences, 2005
- The pathophysiology of cigarette smoking and cardiovascular disease: An updateJournal of the American College of Cardiology, 2004
- The Association of Smoking with CardiomyopathyThe New England Journal of Medicine, 1984